In the news: ObvioHealth just launched an innovative clinical trial for at-home symptomatic COVID-19 patients. Learn more.
In the news: ObvioHealth just launched an innovative clinical trial for at-home symptomatic COVID-19 patients. Learn more.
Objective
A Fortune 500 multinational packaged foods company sought to drive growth in a legacy fiber snack bar brand by launching new product line extensions with a re-formulated fiber ingredient.
Methodology
Development of a research plan to examine 4 test product iterations of an inulin fiber bar amongst 400 participants across the US. The 100% virtual RCT collected data on clinical efficacy, GI tolerance, and consumer perceptions. 400 participants were recruited across 48 states in 24 days.
Results
• The study achieved 85% questionnaire compliance and an impressive 92% retention rate.
• Data dashboards showed live results during the study.
• New insights on GI response and product likeability informed product development & marketing claims.
85%
Questionnaire Compliance
92%
Retention
“I reached out to them several times and they were very prompt in responding.”
-Study Participant
Learn More About Our Virtual Clinical Studies Platform
Fill in the form below and our clinical operations team will be in touch.
Request a demo
Share your email with us and we will share our latest demo with you!
3452 Lake Lynda Drive
Building 100, Suite 151
Orlando, FL 32817
